Ortiz-AlvaradoO, MiyaokaR, KriedbergCet al.Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers. J Endourol, 2011; 25:535–540.
2.
PassmanCM, HolmesRP, KnightJet al.Effect of soda consumption on urinary stone risk parameters. J Endourol, 2009; 23:347–350.
3.
AndersonRA. A complementary approach to urolithiasis prevention. World J Urol, 2002; 20:294–301.
4.
ArsihIW, Madyastutir, PrasetyoBF, AldobrataA. Anti Lithiasis Activity of Avocado (Persea amencana Mill) Leaves Extract in White Male Rats. HAYATI J Biosci, 2012; 19:49–52.
5.
SaxenaA, SharmaRK. Nutritional aspect of nephrolithiasis. Indian J Urol, 2010; 26:523–530.
6.
BellSG, ChenX, SowdenRJet al.Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam. J Am Chem Soc, 2003; 125:705–714.
7.
SirmagulB, AtliO, IlginS. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: A retrospective study. Hum Exp Toxicol, 2012; 31:971–980.
8.
EpsteinM, Gonzalez-PardoL. Intractable seizures: Review and guide for clinical usage of valproic acid. J Kans Med Soc, 1981; 82:58–60.
9.
AkinY, YucelS, DanismanAet al.The impact of metabolic risk management on recurrence of urinary stones. Kuwait Med J, 2012; 44:215–218.
10.
SinghI, BishnoiI, AgarwalV, BhattS. Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤8 mm) nephrolithiasis. Urol Ann, 2011; 3:75–81.
11.
LipkinME, PremingerGM. Demystifying the medical management of nephrolithiasis. Rev Urol, 2011; 13:34–38.
